Alto Neuroscience (ANRO) Reports FY25 Loss of $2.19/Share
Earnings Per Share (GAAP) $-2.19 vs $-0.41 est. Analyst sentiment remains constructive. Despite the loss, the analyst community maintains a ...
Tuesday, September 8, 2026
Tag: ANRO
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.